August 13, 2026

Phoenix Children’s Joins First Controlled Clinical Trial of Genetic Therapy for Dravet Syndrome

The first controlled phase 3 trial of a genetic therapy for Dravet syndrome is now underway – with Phoenix Children's as one of 28 sites nationwide.

Phoenix Children's Medical Connection

August 12, 2026

Redefining Fontan Care: The Socio-Economic Impact of SVHD on Families

Survey results reveal the long-term socio-economic and psychological impacts of single ventricle congenital heart disease (SVHD) on families. See how cardiologists Deepti Bhat, MD, and Naim Duran, MD, contributors to this research, are using findings to transform Fontan Clinic care at Phoenix Children’s.

Phoenix Children's Medical Connection

August 12, 2026

SCPC Care: Non-Age-Related Factors Contribute to Timing

A literature review published in Future Cardiology suggests that providers should look beyond chronological age to various modifiable physiologic factors when planning a superior cavopulmonary connection (SCPC) procedure.

Phoenix Children's Medical Connection

August 07, 2026

Building a Culture Committed to Discovery

Children with congenital heart disease need complex care. Ongoing research into valve durability, placement and reinterventions fuels efforts to improve treatments.

Phoenix Children's Medical Connection

July 31, 2026

Designing AI for Real-World Healthcare

Why local validation, usability, and infrastructure matter as much as algorithm performance

The Pathologist

July 24, 2026

Integrating Environmental Health Into Pediatric Cancer Care May Improve Outcomes

A review of the scientific literature on the impact of environmental factors on the health of pediatric cancer survivors by Omar Shakeel, MD, Assistant Professor in the Department of Pediatrics, Divis...

The ASCO Post

July 24, 2026

Integrating Environmental Health Into Pediatric Cancer Care May Improve Outcomes

A review of the scientific literature on the impact of environmental factors on the health of pediatric cancer survivors by Omar Shakeel, MD, Assistant Professor in the Department of Pediatrics, Divis...

The ASCO Post

July 24, 2026

Bringing it Home: Why We Switched to In-House WGS

Annette Kim shares her experience of a real-world clinical laboratory transition to whole-genome sequencing

The Pathologist

July 16, 2026

Dana-Farber Researchers Identify CDK8 as a Potential Therapeutic Target for Alveolar Rhabdomyosarcoma

Dana-Farber Cancer Institute researchers studied alveolar rhabdomyosarcoma (aRMS), an aggressive childhood cancer with poor survival and few targeted treatment options, to identify new treatment vulnerabilities. Using a network-based analysis of large functional genomic datasets, they found that aRMS cells depend on CDK8, a protein involved in controlling gene activity.

Dana-Farber

July 15, 2026

Myopia Patterns in Intermittent Exotropia

New findings indicate intermittent exotropia may influence binocular ocular growth patterns without significantly increasing myopia risk

The Ophthalmologist